perfosfamide has been researched along with Carcinoma, Anaplastic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benson, NA; Moreb, JS; Ostmark, B; Zucali, JR | 1 |
| Teufel, G | 1 |
| Ayash, LJ; Goff, DA; Holden, SA; Teicher, BA; Tretyakov, O; Wright, JE | 1 |
3 other study(ies) available for perfosfamide and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Heterogeneity of aldehyde dehydrogenase expression in lung cancer cell lines is revealed by Aldefluor flow cytometry-based assay.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma; Cell Line, Tumor; Cell Survival; Cyclophosphamide; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescent Dyes; Humans; Lung Neoplasms; Propidium; Retinal Dehydrogenase; RNA, Small Interfering; Staining and Labeling | 2007 |
[Experiences with Volm's short-term tumor test in the primary treatment of ovarian carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Division; Cells, Cultured; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance; Female; Fluorouracil; Humans; Ovarian Neoplasms; Prognosis; Thymidine; Uridine | 1984 |
Antitumor efficacy and pharmacokinetic analysis of 4-hydroperoxycyclophosphamide in comparison with cyclophosphamide +/- hepatic enzyme effectors.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Survival; Cimetidine; Cyclophosphamide; Cytochrome P-450 Enzyme System; Etanidazole; Female; Half-Life; Ifosfamide; Injections, Intraperitoneal; Liver; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Rats; Rats, Inbred F344 | 1996 |